Charles River Laboratories | CRL - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Agilent USD 1.04B 52M 2026-06
Align Technology USD 757.43M 20.84M 2026-06
Bio-Rad Laboratories USD 345.8M 36.4M 2026-06
Bruker USD 416M 36.2M 2026-06
Cardinal Health USD 2.56B 62M 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Cigna USD 6.08B 50.37B 2026-03
Concord Medical Services Hldg CNY -37.42M 26.25M 2023-06
CVS Health USD 15.75B 125M 2026-06
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
Elevance Health USD 44.33B 32.65B 2026-06
Humana USD 4.82B 754M 2025-06
Illumina USD 770M 49M 2026-06
Incyte USD 1.57B 400.89M 2026-06
Intrexon USD -297K 167K 2024-06
IQVIA Holdings USD 1.44B 368M 2026-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Lonza CHF 1.29B 248M 2025-06
McKesson USD 3.68B 359M 2026-06
Merck EUR 3.17B 101M 2026-06
Mettler Toledo International USD 555.82M 119.62M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Quest Diagnostics USD 906M 33M 2026-03
Revvity USD 416.87M 29.21M 2026-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
United Therapeutics USD 683.8M 35.7M 2026-06
UnitedHealth USD 98.66B 73.25B 2026-06
Veradigm USD 83.44M 3.95M 2022-09
Waters USD 490M 52M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03